Emergent BioSolutions Inc. (EBS)
NYSE: EBS · Real-Time Price · USD
8.53
+0.55 (6.89%)
At close: Jun 26, 2026, 4:00 PM EDT
8.51
-0.02 (-0.19%)
After-hours: Jun 26, 2026, 7:58 PM EDT
Emergent BioSolutions Employees
Emergent BioSolutions had 900 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
900
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$752,000
Profits / Employee
-$9,556
Market Cap
440.12M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Tilray Brands | 2,842 |
| Canopy Growth | 960 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Evolus | 350 |
| Esperion Therapeutics | 294 |
| Akebia Therapeutics | 194 |
| Alpha Teknova | 158 |
EBS News
- 4 days ago - BioMendics Receives FDA Fast Track Designation for BM-3103 (TolaSure® Gel™) for Epidermolysis Bullosa Simplex - Business Wire
- 18 days ago - Emergent BioSolutions Transcript: Goldman Sachs 47th Annual Global Healthcare Conference 2026 - Transcripts
- 23 days ago - Emergent BioSolutions Supports Victoria's Voice Foundation's National Naloxone Awareness Day to Help Save Lives from Opioid Overdose - GlobeNewsWire
- 23 days ago - Emergent BioSolutions Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 4 weeks ago - Emergent BioSolutions awarded $64.5M HHS contract modification - TheFly
- 4 weeks ago - Emergent BioSolutions Receives $64.5 Million Contract Modification for BAT® [Botulism Antitoxin Heptavalent (A, B, C, D, E, F, G) – (Equine)] to Support U.S. Biodefense Strategy - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 weeks ago - Emergent BioSolutions receives Saudi approval for ACAM2000 vaccine - TheFly